St. Jude Medical Company Profile (NYSE:STJ)

About St. Jude Medical

St. Jude Medical logoSt. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company's product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: STJ
  • CUSIP: 79084910
Key Metrics:
  • Previous Close: $79.73
  • 50 Day Moving Average: $80.28
  • 200 Day Moving Average: $73.95
  • 52-Week Range: $48.83 - $84.00
  • Trailing P/E Ratio: 34.67
  • Foreward P/E Ratio: 18.04
  • P/E Growth: 1.72
  • Market Cap: $22.72B
  • Outstanding Shares: 284,929,000
  • Beta: 1.32
  • Net Margins: 11.40%
  • Return on Equity: 27.60%
  • Return on Assets: 9.17%
  • Debt-to-Equity Ratio: 1.27%
  • Current Ratio: 1.71%
  • Quick Ratio: 1.18%
Additional Links:
Companies Related to St. Jude Medical:

Analyst Ratings

Consensus Ratings for St. Jude Medical (NYSE:STJ) (?)
Ratings Breakdown: 19 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.21)
Consensus Price Target: $74.08 (7.09% downside)

Analysts' Ratings History for St. Jude Medical (NYSE:STJ)
DateFirmActionRatingPrice TargetDetails
9/12/2016Jefferies GroupReiterated RatingHold$60.00View Rating Details
8/28/2016ArgusReiterated RatingHoldView Rating Details
8/28/2016Credit Suisse Group AGReiterated RatingNeutral$81.00View Rating Details
8/15/2016Barclays PLCReiterated RatingEqual Weight$83.00View Rating Details
7/20/2016Canaccord GenuitySet Price TargetHold$85.00View Rating Details
7/21/2016Leerink SwannReiterated RatingHold$85.00View Rating Details
7/17/2016JPMorgan Chase & Co.Reiterated RatingHoldView Rating Details
7/15/2016WedbushDowngradeOutperform -> Neutral$70.00 -> $84.00View Rating Details
5/10/2016SunTrust Banks Inc.DowngradeBuy -> Neutral$70.00 -> $80.00View Rating Details
5/2/2016Morgan StanleyDowngradeOverweight -> Equal Weight$67.00 -> $81.00View Rating Details
4/30/2016Wells Fargo & Co.Reiterated RatingHoldView Rating Details
4/29/2016William BlairDowngradeOutperform -> Market PerformView Rating Details
4/29/2016Needham & Company LLCDowngradeBuy -> HoldView Rating Details
4/28/2016Piper Jaffray Cos.DowngradeOverweight -> NeutralView Rating Details
4/18/2016BTIG ResearchDowngradeBuy -> NeutralView Rating Details
4/15/2016Bank of America Corp.Reiterated RatingBuy$66.00View Rating Details
3/28/2016Oppenheimer Holdings Inc.Boost Price TargetMarket Perform$57.00 -> $67.00View Rating Details
3/28/2016Cowen and CompanyUpgradeMarket Perform -> Outperform$66.00 -> $73.00View Rating Details
3/28/2016BMO Capital MarketsBoost Price TargetOutperform$66.00 -> $73.00View Rating Details
3/16/2016NomuraInitiated CoverageBuy$64.00View Rating Details
1/25/2016Royal Bank Of CanadaLower Price TargetSector Perform$66.00 -> $57.00View Rating Details
1/15/2016Deutsche Bank AGLower Price TargetHold$65.00 -> $64.00View Rating Details
1/4/2016Sterne Agee CRTLower Price TargetBuy$81.00 -> $78.00View Rating Details
10/22/2015Stifel NicolausDowngradeBuy -> HoldView Rating Details
9/1/2015Evercore ISIReiterated RatingHold$80.00View Rating Details
8/28/2015S&P Equity ResearchReiterated RatingBuy$92.00View Rating Details
1/29/2015CRT CapitalLower Price TargetBuy$80.00 -> $78.00View Rating Details
(Data available from 9/28/2014 forward)


Earnings History for St. Jude Medical (NYSE:STJ)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/20/2016Q216$1.06$1.06$1.55 billion$1.56 billionViewListenView Earnings Details
4/20/2016Q116$0.88$0.90$1.43 billion$1.45 billionViewListenView Earnings Details
1/27/2016Q415$1.01$1.02$1.48 billion$1.45 billionViewListenView Earnings Details
10/21/2015Q315$0.97$0.97$1.35 billion$1.34 billionViewListenView Earnings Details
7/22/2015Q215$1.00$1.03$1.39 billion$1.41 billionViewListenView Earnings Details
4/22/2015Q115$0.91$0.93$1.35 billionViewN/AView Earnings Details
1/28/2015Q414$1.03$1.03$1.44 billion$1.44 billionViewN/AView Earnings Details
10/15/2014Q314$0.96$0.97$1.39 billion$1.38 billionViewListenView Earnings Details
7/16/2014Q214$1.00$1.02$1.44 billion$1.45 billionViewN/AView Earnings Details
4/16/2014Q114$0.95$0.96$1.36 million$1.36 millionViewN/AView Earnings Details
1/22/2014Q413$0.97$0.99$1.38 billion$1.42 billionViewListenView Earnings Details
10/16/2013Q313$0.89$0.90$1.32 billion$1.34 billionViewListenView Earnings Details
7/17/2013Q2 2013$0.94$0.96$1.36 billion$1.40 billionViewListenView Earnings Details
4/17/2013Q1 2013$0.91$0.92$1.36 billion$1.34 billionViewListenView Earnings Details
1/23/2013Q4 2012$0.87$0.92$1.37 billion$1.37 billionViewListenView Earnings Details
10/17/2012$0.81$0.83ViewN/AView Earnings Details
7/18/2012$0.87$0.86ViewN/AView Earnings Details
4/18/2012$0.83$0.86ViewN/AView Earnings Details
1/25/2012$0.84$0.86ViewN/AView Earnings Details
10/19/2011$0.76$0.78ViewN/AView Earnings Details
7/20/2011$0.84$0.85ViewN/AView Earnings Details
4/20/2011$0.78$0.80ViewN/AView Earnings Details
1/26/2011$0.74$0.75ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for St. Jude Medical (NYSE:STJ)
Current Year EPS Consensus Estimate: $4.06 EPS
Next Year EPS Consensus Estimate: $4.42 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166$0.88$1.04$0.92
Q2 20167$0.99$1.13$1.05
Q3 20166$0.98$1.03$1.01
Q4 20168$1.06$1.11$1.08
Q1 20177$0.98$1.16$1.03
Q2 20176$1.08$1.25$1.16
Q3 20175$1.09$1.16$1.12
Q4 20176$1.15$1.24$1.20
(Data provided by Zacks Investment Research)


Current Dividend Information for St. Jude Medical (NYSE:STJ)
Annual Dividend:$1.24
Dividend Yield:1.56%
Dividend Growth:8.20% (3 Year Average)
Payout Ratio:53.91% (Based on Trailing 12 Months of Earnings)
30.54% (Based on Current Year Consensus EPS Estimate)
28.05% (Based on Next Year Consensus EPS Estimate)
Track Record:5 Years of Consecutive Dividend Growth

Dividend History for St. Jude Medical (NYSE:STJ)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for St. Jude Medical (NYSE:STJ)
Insider Ownership Percentage: 4.80%
Institutional Ownership Percentage: 81.78%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/5/2016Jeff FechoVPSell10,408$51.71$538,197.68View SEC Filing  
12/21/2015Donald ZurbayCFOSell3,106$60.96$189,341.76View SEC Filing  
12/21/2015Jeff DallagerVPSell501$60.94$30,530.94View SEC Filing  
12/18/2015John C HeinmillerEVPSell8,009$61.16$489,830.44View SEC Filing  
10/28/2015Daniel J. StarksCEOSell120,000$62.36$7,483,200.00View SEC Filing  
4/28/2015Daniel J StarksCEOSell100,000$72.46$7,246,000.00View SEC Filing  
4/27/2015Mark W MurphyVPSell5,882$72.45$426,150.90View SEC Filing  
4/24/2015Jason ZellersVPSell3,566$74.13$264,347.58View SEC Filing  
4/24/2015Joel BeckerInsiderSell17,870$73.87$1,320,056.90View SEC Filing  
4/24/2015John C HeinmillerEVPSell160,000$73.69$11,790,400.00View SEC Filing  
4/24/2015Lisa AndradeCMOSell5,000$73.87$369,350.00View SEC Filing  
4/24/2015Stuart EssigDirectorSell7,750$73.85$572,337.50View SEC Filing  
4/22/2015I Paul BaeVPSell34,000$73.00$2,482,000.00View SEC Filing  
4/22/2015Lisa AndradeCMOSell5,000$70.55$352,750.00View SEC Filing  
2/10/2015Michael A RoccaDirectorSell3,875$65.57$254,083.75View SEC Filing  
2/6/2015Michael T RousseauCOOSell7,207$67.31$485,103.17View SEC Filing  
2/3/2015Denis M GestinInsiderSell148,500$67.13$9,968,805.00View SEC Filing  
2/3/2015Scott ThomeVPSell6,666$67.94$452,888.04View SEC Filing  
2/2/2015Mark W MurphyVPSell859$66.92$57,484.28View SEC Filing  
2/2/2015Richard R DevenutiDirectorSell7,750$66.43$514,832.50View SEC Filing  
12/18/2014John C HeinmillerEVPSell6,853$64.60$442,703.80View SEC Filing  
10/27/2014Jeff FechoVPSell500$60.55$30,275.00View SEC Filing  
10/23/2014Jason ZellersVPSell33,999$60.04$2,041,299.96View SEC Filing  
10/22/2014Daniel J StarksCEOSell100,000$60.04$6,004,000.00View SEC Filing  
7/30/2014Mark CarlsonVPSell1,198$66.40$79,547.20View SEC Filing  
7/29/2014Daniel J StarksCEOSell90,000$66.25$5,962,500.00View SEC Filing  
7/29/2014Mark W MurphyVPSell2,000$66.43$132,860.00View SEC Filing  
7/28/2014Denis M GestinInsiderSell99,000$66.76$6,609,240.00View SEC Filing  
7/28/2014Rachel EllingsonVPSell2,630$66.72$175,473.60View SEC Filing  
7/18/2014Scott ThomeVPSell5,997$67.06$402,158.82View SEC Filing  
2/6/2014Michael RoccaDirectorSell5,600$60.36$338,016.00View SEC Filing  
2/5/2014Scott ThomeVPSell7,500$59.57$446,775.00View SEC Filing  
2/4/2014Michael RousseauCOOSell4,644$59.76$277,525.44View SEC Filing  
1/27/2014Jeff FechoVPSell10,408$61.28$637,802.24View SEC Filing  
1/27/2014Joel BeckerInsiderSell14,164$61.58$872,219.12View SEC Filing  
1/24/2014Mark MurphyVPSell9,480$63.14$598,567.20View SEC Filing  
12/18/2013Joel BeckerInsiderSell37,916$59.54$2,257,518.64View SEC Filing  
12/18/2013John HeinmillerEVPSell4,144$59.49$246,526.56View SEC Filing  
12/16/2013Frank CallaghanInsiderSell73,826$59.28$4,376,405.28View SEC Filing  
12/9/2013Daniel StarksCEOSell108,000$59.41$6,416,280.00View SEC Filing  
11/5/2013Daniel StarksCEOSell108,000$57.33$6,191,640.00View SEC Filing  
10/31/2013Michael T RousseauInsiderSell50,000$57.81$2,890,500.00View SEC Filing  
10/29/2013Kathy ChesterVPSell9,375$58.12$544,875.00View SEC Filing  
10/29/2013Michael T RousseauInsiderSell50,000$57.76$2,888,000.00View SEC Filing  
10/28/2013Donald ZurbayCFOSell40,000$57.31$2,292,400.00View SEC Filing  
10/28/2013Mark W MurphyVPSell5,024$57.51$288,930.24View SEC Filing  
10/25/2013Jason ZellersVPSell14,917$57.15$852,506.55View SEC Filing  
10/24/2013Joel BeckerInsiderSell9,613$56.48$542,942.24View SEC Filing  
10/23/2013John C HeinmillerEVPSell150,000$56.48$8,472,000.00View SEC Filing  
10/23/2013Kathy ChesterVPSell20,000$56.50$1,130,000.00View SEC Filing  
10/22/2013Angela D CraigVPSell24,402$56.59$1,380,909.18View SEC Filing  
10/21/2013Frank J CallaghanInsiderSell133,096$56.26$7,487,980.96View SEC Filing  
10/21/2013Mark W MurphyVPSell3,930$56.26$221,101.80View SEC Filing  
10/18/2013Jason ZellersVPSell10,916$56.56$617,408.96View SEC Filing  
10/18/2013Michael T RousseauInsiderSell61,000$56.65$3,455,650.00View SEC Filing  
10/18/2013Wendy L YarnoDirectorSell22,150$56.50$1,251,475.00View SEC Filing  
10/4/2013Denis GestinInsiderSell137,000$55.25$7,569,250.00View SEC Filing  
10/4/2013Donald ZurbayCFOSell12,000$55.55$666,600.00View SEC Filing  
9/11/2013Mark MurphyVPSell4,200$53.50$224,700.00View SEC Filing  
8/9/2013Angela CraigVPSell13,600$54.00$734,400.00View SEC Filing  
8/9/2013Frank CallaghanInsiderSell11,000$54.00$594,000.00View SEC Filing  
7/29/2013Jason ZellersVPSell10,359$52.22$540,946.98View SEC Filing  
7/29/2013Stuart EssigDirectorSell5,600$52.19$292,264.00View SEC Filing  
7/25/2013Kathy ChesterVPSell16,250$52.00$845,000.00View SEC Filing  
7/22/2013Jason ZellersVPSell7,341$51.91$381,071.31View SEC Filing  
7/19/2013Donald ZurbayCFOSell50,000$51.28$2,564,000.00View SEC Filing  
7/19/2013Jeff FechoVPSell13,848$50.82$703,755.36View SEC Filing  
7/19/2013Joel BeckerInsiderSell11,700$50.50$590,850.00View SEC Filing  
5/2/2013Richard R DevenutiDirectorSell5,270$40.64$214,172.80View SEC Filing  
2/5/2013Denis M GestinInsiderSell90,000$41.32$3,718,800.00View SEC Filing  
2/5/2013Thomas R NorthenscoldVPSell22,000$41.40$910,800.00View SEC Filing  
10/25/2012John W BrownDirectorBuy25,000$38.65$966,250.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for St. Jude Medical (NYSE:STJ)
News IconPay Close Attention To These Analyst Ratings Hilton Worldwide Holdings Inc (NYSE:HLT), St. Jude Medical, Inc ... - The Voice Registrar (NYSE:STJ) - September 28 at 7:14 PM logoSt. Jude Medical, Inc. (NYSE:STJ):Consensus Rating At 2.89 - Investor Newswire (NYSE:STJ) - September 28 at 12:17 PM logoMediation Talks Between Abbott and Alere Collapse (NYSE:STJ) - September 28 at 11:56 AM
News IconToday's Top Gainers in the Market St. Jude Medical Inc. (NYSE:STJ) from Healthcare - The Daily Leicester (NYSE:STJ) - September 27 at 12:06 PM logoCan Shares Of St. Jude Medical, Inc. (NYSE:STJ) Hit $89? - Investor Newswire (NYSE:STJ) - September 26 at 7:32 PM
News IconHome Finance Earnings Reaction History: St. Jude Medical Inc. (NYSE:STJ) has a 51.85% chance... - The Independent Republic (NYSE:STJ) - September 26 at 7:32 PM
News IconAnalysts Valuations For Two Stocks: St. Jude Medical, Inc. (NYSE:STJ), Phillips 66 (NYSE:PSX) - The Voice Registrar (NYSE:STJ) - September 26 at 7:32 PM
News IconToday's Top Gainers in the Market St. Jude Medical Inc. (NYSE:STJ ... - The Daily Leicester (NYSE:STJ) - September 24 at 6:43 PM
News IconA look at a High Market Cap Stock: St. Jude Medical Inc., STJ - The Daily Leicester (NYSE:STJ) - September 22 at 7:06 PM
News IconStocks in Frontline Trades' Choice: Medivation, Inc. (NASDAQ:MDVN), St. Jude Medical Inc. (NYSE:STJ) - Street Wise Report (press release) (blog) (NYSE:STJ) - September 22 at 7:06 PM logoSt. Jude Medical, Inc. (NYSE:STJ) Had $667 In Cash And Short-Term Investments - Stocks Daily (NYSE:STJ) - September 22 at 7:06 PM
News IconSt. Jude Medical Inc.'s (STJ): Stock's Financial Statistics - Hot Stocks ... - Hot Stocks Point (NYSE:STJ) - September 21 at 7:01 PM logoSt Jude Medical : Assigned Patent (NYSE:STJ) - September 21 at 11:37 AM logo46.5% Return Seen to Date on SmarTrend St Jude Medical Call (STJ) (NYSE:STJ) - September 19 at 7:26 PM
News IconHigh Market Cap Stock of the Day – St. Jude Medical Inc. (NYSE:STJ) (NYSE:STJ) - September 19 at 7:26 PM logoSt. Jude Medical’s Stock Prices Are on a Declining Trend (NYSE:STJ) - September 19 at 11:42 AM
News IconIs St. Jude Medical Inc. (NYSE:STJ), a large market cap stock a smart buy? (NYSE:STJ) - September 17 at 11:20 AM logoAbbott to sell its eye care business to J&J for about $4.33 billion - Yahoo Finance (NYSE:STJ) - September 16 at 7:11 PM logoTrial Progression of St. Jude Medical's Stroke Prevention Device - Market Realist (NYSE:STJ) - September 16 at 7:11 PM
News IconPay Close Attention To These Analyst Ratings Lowe's Companies, Inc. (NYSE:LOW), St. Jude Medical, Inc. (NYSE:STJ) - The Voice Registrar (NYSE:STJ) - September 15 at 7:35 PM logoSt Jude Medical : Federal Contracts Awarded to Companies in Minnesota (Sept. 14) (NYSE:STJ) - September 14 at 7:40 PM
News IconHC Stocks Overview= Mylan NV (NASDAQ:MYL), St. Jude Medical ... - share market updates (press release) (NYSE:STJ) - September 14 at 11:50 AM
News IconAnalysts Valuations For Two Stocks: St. Jude Medical, Inc. (NYSE:STJ), Gilead Sciences, Inc. (NASDAQ:GILD) - The Voice Registrar (NYSE:STJ) - September 14 at 11:50 AM
News IconSt. Jude Medical Inc. (NYSE: STJ) Hold Rating Reiterated at Jefferies Group - BNB Daily (blog) (NYSE:STJ) - September 14 at 11:50 AM logoChance of St. Jude recall over cybersecurity threat 'practically zero ... - Minneapolis / St. Paul Business Journal (NYSE:STJ) - September 13 at 11:39 AM
News IconHC Stocks Highlights= Celgene Corporation (CELG), St. Jude Medical, Inc. (NYSE:STJ) - share market updates (press release) (NYSE:STJ) - September 13 at 11:39 AM logoChance of St. Jude recall over cybersecurity threat 'practically zero,' analyst says (NYSE:STJ) - September 12 at 7:01 PM
News IconSt. Jude Medical Inc. (NYSE:STJ) from Medical Appliances & Equipment – Todays Top Gains (NYSE:STJ) - September 12 at 11:30 AM logoCan Abbott Labs Find a Cure for Its Ailing Shares? (NYSE:STJ) - September 12 at 11:30 AM logoJefferies Cautions Investors: St. Jude Medical Device Issue Not Over Yet - Benzinga (NYSE:STJ) - September 11 at 11:23 AM logoSt. Jude Medical Sues Muddy Waters (NYSE:STJ) - September 9 at 7:05 PM logoSt Jude Medical Has Returned 45.2% Since SmarTrend Recommendation (STJ) (NYSE:STJ) - September 9 at 7:05 PM
News IconSt. Jude Files Lawsuit Over Medical Device Security Claims (NYSE:STJ) - September 9 at 7:05 PM logoNew Long-Term Data Reaffirm the Benefits of Medtronic’s Micra TPS (NYSE:STJ) - September 9 at 7:05 PM logoJefferies Cautions Investors: St. Jude Medical Device Issue Not Over Yet (NYSE:STJ) - September 9 at 3:48 PM
News IconSt. Jude Medical, Inc. (NYSE:STJ) From The Analysts Point of View (NYSE:STJ) - September 9 at 11:20 AM logoUS health regulator plans 'thorough' probe of St. Jude case (NYSE:STJ) - September 9 at 11:20 AM logoSt. Jude Medical sues short seller Muddy Waters (NYSE:STJ) - September 8 at 7:09 PM
News IconSt. Jude lawsuit: Muddy Waters-MedSec report is false, manipulative (NYSE:STJ) - September 8 at 7:09 PM logoINTERVIEW-U.S. health regulator plans 'thorough' probe of St Jude case (NYSE:STJ) - September 8 at 7:09 PM
News IconAnalysts Valuations For Two Stocks: St. Jude Medical, Inc. (NYSE:STJ), Citizens Financial Group Inc (NYSE:CFG) - The Voice Registrar (NYSE:STJ) - September 8 at 11:22 AM logoSt. Jude Medical Sues Short Seller Over Device Allegations - Wall Street Journal (NYSE:STJ) - September 8 at 11:22 AM logoRPT-St. Jude's lawsuit against short-seller faces steep climb -lawyers (NYSE:STJ) - September 8 at 8:41 AM logoSt. Jude sues short-seller, cyber security firm (NYSE:STJ) - September 7 at 7:37 PM logoSt. Jude's lawsuit against short-seller faces steep climb -lawyers (NYSE:STJ) - September 7 at 7:37 PM logoSt. Jude's lawsuit against short-seller faces steep climb: lawyers (NYSE:STJ) - September 7 at 7:37 PM logoSt. Jude Medical Files Lawsuit Against Muddy Waters And MedSec - Quick Facts (NYSE:STJ) - September 7 at 11:11 AM logoMedical Supplier St. Jude Is Suing Short Seller Muddy Waters (NYSE:STJ) - September 7 at 11:11 AM logoSt. Jude Medical Files Lawsuit Against Muddy Waters (NYSE:STJ) - September 7 at 11:11 AM logoSt. Jude Medical Sues Short Seller Over Device Allegations (NYSE:STJ) - September 7 at 11:11 AM


St. Jude Medical (NYSE:STJ) Chart for Wednesday, September, 28, 2016

Last Updated on 9/28/2016 by Staff